RETA
Reata Pharmaceuticals Inc - Ordinary Shares - Class A

2,864
Loading...
Loading...
News
all
press releases
News Placeholder
Kirby McInerney LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Reata Pharmaceuticals, Inc. Common Stock
Kirby McInerney LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Reata Pharmaceuticals, Inc. Common Stock Kirby McInerney LLP Announces Pendency of Class Action...
PR Newswire·2y ago

Latest RETA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.